SECOND ADDENDUM TO LICENSE AND SERVICE AGREEMENTLicense and Service Agreement • May 10th, 2021 • Revance Therapeutics, Inc. • Pharmaceutical preparations
This Second Addendum to License and Service Agreement (this “Second Addendum”) is executed as of March 2, 2021 (the “Second Addendum Date”) by and between Revance Therapeutics, Inc. (“Revance”) and List Biological Laboratories, Inc. (“List” and together with Revance, the “Parties”).
